Exascale Labs FY26 Revenue Jumps 111% to $14.8M Post-Nasdaq Debut

Exascale Labs Holdings Inc. (Nasdaq: XLAB) reported on 28 September 2026 that full fiscal year 2026 revenue rose 111.3% to $14.8 million, up from $7.0 million a year earlier, while its net loss widened to $12.2 million from $7.7 million. The Houston-based AI compute infrastructure provider said its intelligent computing power service grew 124% and that Class A shares and warrants began trading on the Nasdaq Global Market on 28 August 2026, following the close of its business combination with D. Boral ARC Acquisition I Corp.

Context — Why Exascale's First Public Filing Matters Now

The fiscal 2026 period is the company's last as a standalone private entity. Its balance sheet as of 30 June 2026 does not reflect the August 2026 business combination, which the company treats as a subsequent event. That distinction matters because the financial statements investors are reading describe a company that no longer exists in the same legal form.

Exascale entered public markets through a SPAC combination, a route that has drawn scrutiny across the broader AI infrastructure sector. The company said the closing gave it access to roughly $11.8 million in net cash proceeds. That figure is small relative to the capital needs of GPU-heavy infrastructure buildouts, which is why the company's stated fiscal 2027 priorities lean on capacity expansion rather than near-term profitability.

Management framed the year as foundational. Chief Executive Officer Hoansoo Lee said fiscal 2026 was "the year we laid the foundation to become a public company." The company pointed to a qualified customer pipeline of approximately $300 million, a figure it did not break down by contract stage or timing.

Exascale also signed a memorandum of understanding with EnergyBank covering floating offshore wind power and long-duration storage, and a letter of intent with Compal Electronics on a U.S.-based native 800 VDC validation platform. Both are non-binding. The company did not disclose financial terms for either.

Data — What the FY26 Numbers Show

The revenue line is the headline, but the cost structure tells the more useful story. Gross profit rose to $2.4 million from $1.1 million, with gross margin at 16.3% versus 15.8% a year earlier. Total operating expenses climbed to $7.2 million from $4.2 million, driven by a $2.7 million increase in research and development and a $0.9 million rise in general and administrative costs, partly offset by a $0.5 million drop in selling and marketing.

Metric	FY 2025	FY 2026	Change
Revenue	$7.0M	$14.8M	+111.3%
Gross profit	$1.1M	$2.4M	+118.8%
Gross margin	15.8%	16.3%	+50 bps
Operating expenses	$4.2M	$7.2M	+73.9%
Net loss	$7.7M	$12.2M	Wider

The net loss increase traces partly to a $7.4 million non-cash fair value adjustment on the company's simple agreements for future equity, up from $4.6 million a year earlier. Those SAFEs carried an aggregate fair value of roughly $29.1 million as of 30 June 2026 and converted into Class A common stock at the 27 August 2026 closing, removing the liability. Cash stood at $2.7 million, supplemented by $11.8 million in net proceeds from the combination.

Analysis — Reading the Margin and the Pipeline

A 16.3% gross margin is thin for a company positioning itself as a software-defined platform. The modest 50 basis point improvement suggests that scale is not yet translating into pricing power, and that GPU capacity costs still dominate the unit economics. That is the central tension in the AI compute space: operators that own or host hardware carry heavy depreciation and power costs, while pure orchestration software carries higher margins but less defensibility.

Exascale is betting on the hardware-adjacent side. Its 800 VDC work with Compal and its modular cooling and HVDC power offerings address power density, which the company's Head of R&D Zach Bright called "a real bottleneck for AI infrastructure, not just GPU supply." That framing puts Exascale in competition with well-capitalized data center operators and power infrastructure firms rather than only with GPU cloud providers.

The pipeline figure deserves caution. A roughly $300 million qualified pipeline is not backlog, and the company itself said its focus is on "transitioning these agreements into signed contracts." The MOU and LOI are explicitly non-binding.

The $11.8 million in combination proceeds is modest against the capital intensity of North American, Asian and European host-site expansion. Exascale's ability to fund capacity growth without further dilution is the open question the report does not answer.

Outlook — What to Watch for XLAB

Three catalysts sit on the near-term calendar, all company-stated rather than scheduled. First, conversion of the Compal LOI into a definitive agreement on the 800 VDC validation platform. Second, any update on the EnergyBank MOU moving toward binding terms. Third, disclosure of the post-combination balance sheet, which will show the effect of SAFE conversion and the cash position as of the closing date.

The company's fiscal 2027 pillars are capacity expansion across North America, Asia and Europe, commercialization of its 800 VDC and high-density cooling products, and monetization of its GPU orchestration software among AI operators. Progress on gross margin, which sat at 16.3% in fiscal 2026, is the cleanest single indicator of whether scale is working. Renewal rate, reported at roughly 68%, is the second.

No price levels are established for the shares given the recent listing date, and the company gave no revenue or earnings guidance for fiscal 2027.

Frequently Asked Questions

What does Exascale Labs' FY26 revenue growth mean for retail investors?

The 111% revenue increase to $14.8 million shows demand for the company's GPU-as-a-Service offering expanded, but the $12.2 million net loss and 16.3% gross margin show the business is not yet profitable. Retail investors should weigh the growth rate against the capital needs of expanding GPU capacity, particularly given the modest $11.8 million in net proceeds from the business combination.

What happens next for XLAB shares after the Nasdaq listing?

The company listed on 28 August 2026 and reported results on 28 September 2026, so no long trading history exists. Near-term focus is on whether the non-binding Compal LOI and EnergyBank MOU become definitive agreements, and whether the roughly $300 million qualified pipeline converts into signed contracts. The company provided no fiscal 2027 revenue guidance.

Why did Exascale's net loss widen despite revenue more than doubling?

Operating expenses grew 73.9% to $7.2 million, led by a $2.7 million increase in research and development. A $7.4 million non-cash fair value adjustment on SAFEs also weighed on the result, up from $4.6 million a year earlier. That SAFE charge is non-cash and the instruments converted to Class A stock at the August 2026 closing.

Bottom Line

Exascale doubled revenue but still loses money on thin margins, making pipeline conversion and gross margin the only metrics that matter from here.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.